RecruitingNCT07393672
Hemp-derived cannabinoids for menopause symptoms
About this title
Read the official source — NCT07393672Medication studyAges 40–60United StatesAnxiety
Understand this study
Who could participate?
Listed age limits: 40 years to 60 years.
- Listed locations
- PullmanSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 11, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 104
- Sponsor
- Washington State University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 40 Years to 60 Years
- Official registry ID
- NCT07393672
- Official title
Show the full official title
Effects of Hemp-Derived Cannabinoids on Menopause Symptoms
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Pullman
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Washington State University, a university.
Does this study involve medication?
Yes. The study involves medication, including Hemp-derived cannabinoids and Placebo.
Who can participate?
Listed age limits: 40 years to 60 years.
Is this study still recruiting?
The registry lists this study as recruiting.
